DIEGO
ALONSO LÓPEZ
Investigador
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (10)
2023
-
Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice
Nature Communications, Vol. 14, Núm. 1
-
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer
Molecular cancer, Vol. 22, Núm. 1, pp. 119
2022
-
Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
Cancer research, Vol. 82, Núm. 6, pp. 1098-1109
2020
-
Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients
Pharmacogenomics Journal, Vol. 20, Núm. 5, pp. 664-671
-
Stromal SNAI2 is required for ERBB2 breast cancer progression
Cancer Research, Vol. 80, Núm. 23, pp. 5216-5230
-
Systematic comparison and assessment of RNA-seq procedures for gene expression quantitative analysis
Scientific Reports, Vol. 10, Núm. 1
-
Transcriptomic analysis of patients with immune thrombocytopenia treated with eltrombopag
Platelets, Vol. 31, Núm. 8, pp. 993-1000
2017
-
MicroRNA (miR)-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma
British Journal of Dermatology, Vol. 177, Núm. 1, pp. 168-178
2015
-
Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach
Genome Biology, Vol. 16, Núm. 1
2012
-
A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors
EMBO Journal, Vol. 31, Núm. 18, pp. 3704-3717